News » Archives » October 2014

New study identifies potential targets for personalized cancer vaccines

Author: Stephanie Healey

New study identifies potential targets for personalized cancer vaccines

A team of University of Notre Dame scientists, in collaboration with researchers at the University of Connecticut, have announced the results of a new study on identifying potential targets for personalized cancer vaccines. The paper, “Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity,” was recently published in the Journal of Experimental Medicine. The research group at Notre Dame was led by Brian Baker, associate dean for research and graduate studies and professor of chemistry and biochemistry, and included Steven Corcelli, associate professor of chemistry and biochemistry, and graduate student Cory Ayers.

Read More

October’s Talk Science highlights diabetes and cancer immunotherapy research

Author: Casey O'Donnell

Jeff Hansen

Every month, Notre Dame students gather in the Jordan Hall of Science to learn about ongoing scientific research at the University.

Called Talk Science, this monthly event is organized by Scientia, Notre Dame’s Undergraduate Journal of Scientific Research. Students enjoy pizza and beverages while listening to presentations by undergraduate and faculty researchers. These presentations encourage students to engage with research outside their disciplines and give them a glimpse of a few of the myriad opportunities available for research at Notre Dame. On Wednesday, October 8, students heard from Jeff Hansen and Professor Brian Baker.

Read More